BENEVENTO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 142
EU - Europa 99
AS - Asia 86
OC - Oceania 6
SA - Sud America 2
AF - Africa 1
Totale 336
Nazione #
US - Stati Uniti d'America 137
CN - Cina 48
IT - Italia 30
FR - Francia 21
IE - Irlanda 17
JP - Giappone 12
DE - Germania 8
BG - Bulgaria 7
IN - India 7
AU - Australia 5
CA - Canada 5
TR - Turchia 5
ES - Italia 3
HK - Hong Kong 3
IR - Iran 3
AR - Argentina 2
BE - Belgio 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
SE - Svezia 2
SG - Singapore 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
DZ - Algeria 1
FI - Finlandia 1
KR - Corea 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 336
Città #
Bologna 17
Dublin 17
Ashburn 12
Seattle 11
Santa Cruz 10
Boardman 9
Fairfield 7
Sofia 7
Buffalo 5
Chicago 5
Tokyo 5
Beijing 4
Guangzhou 4
Mumbai 4
New York 4
Shanghai 4
Sydney 4
Chengdu 3
Hayamiya 3
San Diego 3
Wilmington 3
Bethesda 2
Brussels 2
Buenos Aires 2
Cedar Knolls 2
Chandler 2
Crugers 2
Istanbul 2
Kyoto 2
Los Angeles 2
Maltepe 2
Paris 2
Rome 2
Stockholm 2
Washington 2
Andria 1
Ankara 1
Auckland 1
Bangkok 1
Batna City 1
Bremen 1
Calgary 1
Central 1
Council Bluffs 1
Dalian 1
Dallas 1
Decatur 1
Denver 1
East Orange 1
Esslingen am Neckar 1
Foshan 1
Frankfurt am Main 1
Grenoble 1
Gyeryong 1
Haidian 1
Hangzhou 1
Hefei 1
Helsinki 1
Henderson 1
Higashinippori 1
Hillsboro 1
Hobart 1
Ivrea 1
Kazan' 1
Lake Forest 1
Las Vegas 1
Leeuwarden 1
Lexington 1
León 1
London 1
Milpitas 1
Mountain View 1
Murcia 1
Neckartenzlingen 1
Nice 1
Palo Alto 1
Pune 1
Ragusa 1
Riva 1
Rozzano 1
San Jose 1
San Sebastián de los Reyes 1
Schio 1
Shenzhen 1
Sibiu 1
Southend 1
Taichung 1
Taipei 1
Tampa 1
Tehran 1
Woodbridge 1
Totale 225
Nome #
Experience with regorafenib in the treatment of hepatocellular carcinoma, file e1dcb339-0004-7715-e053-1705fe0a6cc9 136
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma, file e1dcb337-9a4e-7715-e053-1705fe0a6cc9 77
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis, file e1dcb336-4552-7715-e053-1705fe0a6cc9 46
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort, file e1dcb339-70c1-7715-e053-1705fe0a6cc9 23
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery, file e1dcb336-a806-7715-e053-1705fe0a6cc9 17
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort, file 8aa82fd8-f407-4b64-a57f-1adf3a92a93d 10
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC, file f5a942b2-3275-42c5-9aa4-4273688464dd 6
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients, file d2b192e3-d31f-4e67-b2c8-a9aa8940d38e 5
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma, file 473dc475-b8ca-4079-a115-c4d2dc3af6d9 4
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs, file 4a6919ef-7e88-4d9a-9a1e-646cc39746e8 2
null, file e1dcb32f-575f-7715-e053-1705fe0a6cc9 2
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis, file e1dcb336-ff71-7715-e053-1705fe0a6cc9 2
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival, file 06c302eb-3b45-4b6a-a7c7-3465d2b981fd 1
null, file e1dcb32d-bb7f-7715-e053-1705fe0a6cc9 1
null, file e1dcb330-47fa-7715-e053-1705fe0a6cc9 1
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma, file e1dcb330-6782-7715-e053-1705fe0a6cc9 1
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives, file e1dcb331-f186-7715-e053-1705fe0a6cc9 1
Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear, file e1dcb334-1a8c-7715-e053-1705fe0a6cc9 1
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study, file e1dcb336-72ff-7715-e053-1705fe0a6cc9 1
Totale 337
Categoria #
all - tutte 1.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 1 0 0 0
2020/202116 0 1 0 0 0 0 0 2 0 9 2 2
2021/202255 2 3 3 2 4 1 5 3 1 12 15 4
2022/2023113 3 2 9 13 2 0 6 10 30 11 15 12
2023/2024147 9 9 15 11 12 18 26 14 15 18 0 0
Totale 337